TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
16,903,445
|
14,859,454
|
12,556,103 |
| Financial expenses |
847,543
|
780,486
|
332,112 |
| Earnings before taxes |
2,862,162
|
1,984,126
|
2,219,203 |
| EBITDA |
6,071,783
|
4,858,893
|
4,067,536 |
| Total assets |
48,997,714
|
49,722,047
|
35,079,572 |
| Current assets |
8,548,167
|
8,510,787
|
7,491,563 |
| Current liabilities |
7,838,309
|
12,825,624
|
9,927,941 |
| Equity capital |
26,164,067
|
22,747,600
|
17,724,887 |
| - share capital |
126,644
|
130,305
|
113,600 |
| Employees (average) |
1,840
|
1,772
|
1,556 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
53.4%
|
45.7%
|
50.5% |
| Turnover per employee |
9,187
|
8,386
|
8,069 |
| Profit as a percentage of turnover |
16.9%
|
13.4%
|
17.7% |
| Return on assets (ROA) |
7.6%
|
5.6%
|
7.3% |
| Current ratio |
109.1%
|
66.4%
|
75.5% |
| Return on equity (ROE) |
10.9%
|
8.7%
|
12.5% |
| Change turnover |
2,535,484
|
2,238,691
|
2,179,109 |
| Change turnover % |
18%
|
18%
|
21% |
| Chg. No. of employees |
68
|
216
|
-3 |
| Chg. No. of employees % |
4%
|
14%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.